Home › Compare › MKGP vs MRK

MKGP vs MRK: Dividend Comparison 2026

MKGP yields 29411.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MKGP wins by $2.4250103767013817e+21M in total portfolio value
10 years
MKGP
MKGP
● Live price
29411.76%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.4250103767013817e+21M
Annual income
$2,408,898,902,963,155,000,000,000,000.00
Full MKGP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MKGP vs MRK

📍 MKGP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMKGPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MKGP + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MKGP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MKGP
Annual income on $10K today (after 15% tax)
$2,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$2,047,564,067,518,682,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MKGP beats the other by $2,047,564,067,518,682,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MKGP + MRK for your $10,000?

MKGP: 50%MRK: 50%
100% MRK50/50100% MKGP
Portfolio after 10yr
$1.2125051883506909e+21M
Annual income
$1,204,449,451,481,577,600,000,000,000.00/yr
Blended yield
99.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MKGP
No analyst data
Altman Z
-3.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MKGP buys
0
MRK buys
0
No recent congressional trades found for MKGP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMKGPMRK
Forward yield29411.76% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$2.4250103767013817e+21M$56.8K ✓
Annual income after 10y$2,408,898,902,963,155,000,000,000,000.00 ✓$9,798.13
Total dividends collected$2.423950202502082e+21M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MKGP vs MRK ($10,000, DRIP)

YearMKGP PortfolioMKGP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,951,876$2,941,176.47$11,206$366.19+$2.94M → MKGP
2$814,559,407$811,400,899.01$12,650$502.35+$814.55M → MKGP
3$210,126,793,979$209,255,215,413.30$14,407$694.19+$210126.78M → MKGP
4$50,673,675,611,504$50,448,839,941,947.30$16,585$967.82+$50673675.59M → MKGP
5$11,424,428,039,041,414$11,370,207,206,137,104.00$19,342$1,363.89+$11424428039.02M → MKGP
6$2,407,947,461,631,843,000$2,395,723,323,630,068,700.00$22,913$1,947.19+$2407947461631.82M → MKGP
7$474,493,288,024,266,200,000$471,916,784,240,320,100,000.00$27,662$2,823.89+$474493288024266.19M → MKGP
8$87,416,699,772,033,780,000,000$86,908,991,953,847,810,000,000.00$34,159$4,173.35+$87416699772033776.00M → MKGP
9$15,057,452,091,800,826,000,000,000$14,963,916,223,044,750,000,000,000.00$43,337$6,308.80+$15057452091800825856.00M → MKGP
10$2,425,010,376,701,382,000,000,000,000$2,408,898,902,963,155,000,000,000,000.00$56,776$9,798.13+$2.4250103767013817e+21M → MKGP

MKGP vs MRK: Complete Analysis 2026

MKGP — Stock

Maverick Energy Group, Ltd. operates as a natural gas and crude oil exploration and production company. The company focuses on the development and acquisition of producing natural gas and oil properties onshore North America. It is involved in drilling the Larremore field located in Caldwell County in south Texas; operating the Big Foot Field located in Frio and Atascosa counties in Texas; and owning seven producing gas wells in West Virginia. The company also acquires 100% interest Couch leases that cover approximately 800 acres adjacent to the Big Foot Field; and holds interests in the Eagle Ford shale located in south Texas. Maverick Energy Group, Ltd. is based in Tulsa, Oklahoma.

Full MKGP Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MKGP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MKGP vs SCHDMKGP vs JEPIMKGP vs OMKGP vs KOMKGP vs MAINMKGP vs JNJMKGP vs ABBVMKGP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.